[Impact of prior sinus surgery on the efficacy of stapokibart in refractory chronic rhinosinusitis with nasal polyps: a post hoc analysis of the CROWNS-2 trial].

Regardless of prior sinus surgery, stapokibart significantly reduces nasal polyp burden, improves symptoms and quality of life, and decreases the predicted need for further surgery in patients with RCRSwNP.